Dimitris P. Lapatsanis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dimitris P. Lapatsanis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Athanasios G. Pantelis
Surgical Department of Obesity and Metabolic Disorders, Psychiko Clinic, Athens Medical Center, Athens, Greece
3 shared publications - Evangelia Dimitrakopoulou
University Surgical Department, General and Oncological Hospital of Kifissia “Agioi Anargyroi”, Athens, Greece
2 shared publications - Moysis Moysidis
3rd Surgical Department, AHEPA University Hospital, Thessaloniki, Greece
2 shared publications - Vasiliki Tseliou
Surgical Department of Obesity and Metabolic Disorders, Psychiko Clinic, Athens Medical Center, Athens, Greece
2 shared publications - Zoe Pafili
Surgical Department of Obesity and Metabolic Disorders, Psychiko Clinic, Athens Medical Center, Athens, Greece
2 shared publications Panagiota Epiphaniou
1 shared publication
Latest Publications
- 12 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5543
Publisher Correction: Chronodisruption as an Emerging Determinant of Weight Loss Trajectories After Metabolic Bariatric Surgery: A Scoping Review
- 12 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5543
Publisher Correction: Chronodisruption as an Emerging Determinant of Weight Loss Trajectories After Metabolic Bariatric Surgery: A Scoping Review
- 29 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (9) , 4937-4960
Chronodisruption as an Emerging Determinant of Weight Loss Trajectories after Metabolic Bariatric Surgery: A Scoping Review
- 29 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (9) , 4937-4960
Chronodisruption as an Emerging Determinant of Weight Loss Trajectories after Metabolic Bariatric Surgery: A Scoping Review
- Open Access
- 2 July 2025
- Published by OAE Publishing Inc. in Artificial Intelligence Surgery
- Vol. 5 (3) , 322-44
Machine learning and artificial intelligence for predicting short and long-term complications following metabolic bariatric surgery - a systematic review
Background: Machine learning (ML) and other applications of artificial intelligence (AI) are revolutionizing medicine, particularly in the field of surgery. These models have the potential to outperform traditional predictive tools, aiding clinicians in decision making and enhancing operative safety through improved patient selection. Methods: A systematic search was conducted across PubMed/MEDLINE and Google Scholar, guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement, to identify studies employing ML and AI algorithms to predict postoperative complications following metabolic bariatric surgery (MBS). The search included primary studies published in English up to November 2024. The area under the receiver operating characteristic curve (AUROC) was used as a surrogate metric for algorithm performance, with values exceeding 0.8 considered clinically significant; however, studies were not excluded based on AUROC thresholds. Results: The search identified 23 studies meeting the inclusion criteria. These were categorized into seven domains: general complications (8 studies, 34.8%), readmissions after MBS (4 studies, 17.4%), hemorrhage (1 study, 4.3%), leaks (1 study, 4.3%), venous thromboembolism (3 studies, 13.0%), nutritional deficiencies (4 studies, 17.4%), and miscellaneous complications such as gastroesophageal reflux disease, gallbladder disease, and major adverse cardiovascular events (MACE) (3 studies, 13.0%). The studies spanned from 2007 to 2024, with 87.0% (20/23) published in or after 2019. In total, 87 AI/ML algorithms were analyzed. While several studies reported AUROC values exceeding 0.7, the highest achieved was 0.94. However, most studies exhibited methodological limitations, including a lack of external validation and inadequate handling of imbalanced datasets, where complication events were markedly fewer than non-events. Conclusions: While AI and ML approaches generally outperform traditional predictive models in forecasting postoperative complications following MBS, few algorithms demonstrated clinically significant performance with AUROC values above 0.8. Future research should adopt more rigorous methodologies and implement strategies to address imbalanced datasets, ensuring broader clinical applicability of AI/ML tools.
- 2 July 2025
- Published by OAE Publishing Inc. in Artificial Intelligence Surgery
- Vol. 5 (3) , 322-44
Open AccessMachine learning and artificial intelligence for predicting short and long-term complications following metabolic bariatric surgery - a systematic review
Background: Machine learning (ML) and other applications of artificial intelligence (AI) are revolutionizing medicine, particularly in the field of surgery. These models have the potential to outperform traditional predictive tools, aiding clinicians in decision making and enhancing operative safety through improved patient selection. Methods: A systematic search was conducted across PubMed/MEDLINE and Google Scholar, guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement, to identify studies employing ML and AI algorithms to predict postoperative complications following metabolic bariatric surgery (MBS). The search included primary studies published in English up to November 2024. The area under the receiver operating characteristic curve (AUROC) was used as a surrogate metric for algorithm performance, with values exceeding 0.8 considered clinically significant; however, studies were not excluded based on AUROC thresholds. Results: The search identified 23 studies meeting the inclusion criteria. These were categorized into seven domains: general complications (8 studies, 34.8%), readmissions after MBS (4 studies, 17.4%), hemorrhage (1 study, 4.3%), leaks (1 study, 4.3%), venous thromboembolism (3 studies, 13.0%), nutritional deficiencies (4 studies, 17.4%), and miscellaneous complications such as gastroesophageal reflux disease, gallbladder disease, and major adverse cardiovascular events (MACE) (3 studies, 13.0%). The studies spanned from 2007 to 2024, with 87.0% (20/23) published in or after 2019. In total, 87 AI/ML algorithms were analyzed. While several studies reported AUROC values exceeding 0.7, the highest achieved was 0.94. However, most studies exhibited methodological limitations, including a lack of external validation and inadequate handling of imbalanced datasets, where complication events were markedly fewer than non-events. Conclusions: While AI and ML approaches generally outperform traditional predictive models in forecasting postoperative complications following MBS, few algorithms demonstrated clinically significant performance with AUROC values above 0.8. Future research should adopt more rigorous methodologies and implement strategies to address imbalanced datasets, ensuring broader clinical applicability of AI/ML tools.